Market Closed -
OTC Markets
12:51:17 2024-05-17 pm EDT
|
5-day change
|
1st Jan Change
|
0.03
USD
|
+17.19%
|
|
+17.19%
|
-14.29%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
4.673
|
1.819
|
2.547
|
0.5457
|
2.55
|
1.91
|
Enterprise Value (EV)
1 |
6.034
|
3.67
|
4.959
|
3.589
|
6.019
|
6.021
|
P/E ratio
|
-4.94
x
|
-1.93
x
|
-2.11
x
|
-0.49
x
|
-2.12
x
|
-1.59
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
20.1
x
|
9.34
x
|
49.1
x
|
5.72
x
|
38
x
|
19
x
|
EV / Revenue
|
25.9
x
|
18.8
x
|
95.7
x
|
37.6
x
|
89.7
x
|
60
x
|
EV / EBITDA
|
-8.96
x
|
-5.05
x
|
-5.14
x
|
-4.23
x
|
-5.59
x
|
-6.68
x
|
EV / FCF
|
-78.5
x
|
-35.1
x
|
-46.7
x
|
-16.7
x
|
-83.2
x
|
-25.5
x
|
FCF Yield
|
-1.27%
|
-2.85%
|
-2.14%
|
-5.99%
|
-1.2%
|
-3.92%
|
Price to Book
|
-0.62
x
|
-0.25
x
|
-0.3
x
|
-0.06
x
|
-0.24
x
|
-0.16
x
|
Nbr of stocks (in thousands)
|
31,154
|
36,381
|
36,381
|
36,381
|
36,381
|
36,381
|
Reference price
2 |
0.1500
|
0.0500
|
0.0700
|
0.0150
|
0.0701
|
0.0525
|
Announcement Date
|
4/17/18
|
3/29/19
|
5/14/20
|
3/31/21
|
3/31/22
|
4/17/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
0.2328
|
0.1947
|
0.0518
|
0.0955
|
0.0671
|
0.1003
|
EBITDA
1 |
-0.6731
|
-0.727
|
-0.9644
|
-0.8477
|
-1.076
|
-0.9016
|
EBIT
1 |
-0.6745
|
-0.7283
|
-0.9774
|
-0.8604
|
-1.089
|
-0.9142
|
Operating Margin
|
-289.75%
|
-374.12%
|
-1,886.26%
|
-901.36%
|
-1,623.52%
|
-911.43%
|
Earnings before Tax (EBT)
1 |
-0.9365
|
-0.9324
|
-1.208
|
-1.112
|
-1.204
|
-1.202
|
Net income
1 |
-0.9365
|
-0.9324
|
-1.208
|
-1.112
|
-1.204
|
-1.202
|
Net margin
|
-402.28%
|
-478.94%
|
-2,332.13%
|
-1,164.86%
|
-1,794.56%
|
-1,198.73%
|
EPS
2 |
-0.0304
|
-0.0259
|
-0.0332
|
-0.0306
|
-0.0331
|
-0.0330
|
Free Cash Flow
1 |
-0.0768
|
-0.1047
|
-0.1062
|
-0.215
|
-0.0723
|
-0.2363
|
FCF margin
|
-33%
|
-53.76%
|
-204.9%
|
-225.21%
|
-107.82%
|
-235.6%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/17/18
|
3/29/19
|
5/14/20
|
3/31/21
|
3/31/22
|
4/17/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
1.36
|
1.85
|
2.41
|
3.04
|
3.47
|
4.11
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-2.021
x
|
-2.546
x
|
-2.502
x
|
-3.591
x
|
-3.223
x
|
-4.56
x
|
Free Cash Flow
1 |
-0.08
|
-0.1
|
-0.11
|
-0.21
|
-0.07
|
-0.24
|
ROE (net income / shareholders' equity)
|
13.1%
|
12.6%
|
15.4%
|
12.3%
|
11.9%
|
10.7%
|
ROA (Net income/ Total Assets)
|
-122%
|
-136%
|
-205%
|
-165%
|
-211%
|
-196%
|
Assets
1 |
0.7652
|
0.6868
|
0.5895
|
0.6746
|
0.5696
|
0.6145
|
Book Value Per Share
2 |
-0.2400
|
-0.2000
|
-0.2300
|
-0.2600
|
-0.2900
|
-0.3200
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
1 |
0
|
-
|
-
|
0
|
-
|
0.01
|
Capex / Sales
|
1.03%
|
-
|
-
|
0.42%
|
-
|
5.21%
|
Announcement Date
|
4/17/18
|
3/29/19
|
5/14/20
|
3/31/21
|
3/31/22
|
4/17/23
|
|
1st Jan change
|
Capi.
|
---|
| -14.29% | 1.09M | | +5.41% | 106B | | -3.11% | 64.74B | | +73.33% | 49.34B | | +17.24% | 39.15B | | +6.13% | 32.86B | | +12.77% | 20.29B | | +15.03% | 17.21B | | +19.06% | 15.28B | | +6.28% | 14.58B |
Other Commodity Chemicals
|